Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow stem cells for dry AMD
NCT02016508Phase 2Unknown
- Sponsor
- Al-Azhar University
- Start
- Mar 2013
- Primary completion
- Apr 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial in age-related macular degeneration (AMD) and geographic atrophy (GA), sponsored by Al-Azhar University. Primary endpoint: Number of subjects with adverse events at 6 months. Status: unknown.
02
Conditions
age-related macular degeneration (AMD)geographic atrophy (GA)
Beyond the preview
Go deeper on NCT02016508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02016508.